Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Are non-prescription medications needed for weight control?

Bray GA.

Obesity (Silver Spring). 2008 Mar;16(3):509-14. doi: 10.1038/oby.2007.100. Epub 2008 Jan 31. Review. Erratum in: Obesity (Silver Spring). 2008 Jul;16(7):1723.

2.

Compliance, behavior change, and weight loss with orlistat in an over-the-counter setting.

Schwartz SM, Bansal VP, Hale C, Rossi M, Engle JP.

Obesity (Silver Spring). 2008 Mar;16(3):623-9. doi: 10.1038/oby.2007.96. Epub 2008 Jan 24.

3.

A perspective on the current strategies for the treatment of obesity.

Joyal SV.

Curr Drug Targets CNS Neurol Disord. 2004 Oct;3(5):341-56. Review.

PMID:
15544444
4.

Orlistat: current status in clinical therapeutics.

McClendon KS, Riche DM, Uwaifo GI.

Expert Opin Drug Saf. 2009 Nov;8(6):727-44. Review.

PMID:
19998527
5.

Dietary supplements in weight reduction.

Dwyer JT, Allison DB, Coates PM.

J Am Diet Assoc. 2005 May;105(5 Suppl 1):S80-6. Review.

PMID:
15867902
6.

A comparison of meal replacements and medication in weight maintenance after weight loss.

LeCheminant JD, Jacobsen DJ, Hall MA, Donnelly JE.

J Am Coll Nutr. 2005 Oct;24(5):347-53.

PMID:
16192259
7.

Pharmacological therapies for obesity.

Kaplan LM.

Gastroenterol Clin North Am. 2005 Mar;34(1):91-104. Review.

PMID:
15823441
8.

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up.

Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP.

J Am Diet Assoc. 2007 Oct;107(10):1755-67. Review.

PMID:
17904936
9.

Over-the-counter weight loss with orlistat?

[No authors listed]

Drug Ther Bull. 2009 Nov;47(11):125-7. doi: 10.1136/dtb.2009.10.0046.

PMID:
19887686
10.

Over-the-counter orlistat. A weight loss "Alli" or adversary on the horizon.

Anderson T.

AWHONN Lifelines. 2006 Oct-Nov;10(5):418-21. No abstract available.

PMID:
17069574
11.

Use of dietary supplements for weight loss in the United States: results of a national survey.

Pillitteri JL, Shiffman S, Rohay JM, Harkins AM, Burton SL, Wadden TA.

Obesity (Silver Spring). 2008 Apr;16(4):790-6. doi: 10.1038/oby.2007.136. Epub 2008 Jan 24.

12.

Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.

Elfhag K, Finer N, Rössner S.

Diabetes Obes Metab. 2008 Jun;10(6):498-505. Epub 2007 Jun 26.

PMID:
17593239
13.

Currently available drugs for the treatment of obesity: Sibutramine and orlistat.

Chaput JP, St-Pierre S, Tremblay A.

Mini Rev Med Chem. 2007 Jan;7(1):3-10. Review. Erratum in: Mini Rev Med Chem. 2009 Feb;9(2):272.

PMID:
17266632
15.
16.

Medications as adjunct therapy for weight loss: approved and off-label agents in use.

Moyers SB.

J Am Diet Assoc. 2005 Jun;105(6):948-59. Review. Erratum in: J Am Diet Assoc. 2005 Dec;105(12):1869.

PMID:
15942547
17.

The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome.

Svendsen M, Helgeland M, Tonstad S.

J Hum Nutr Diet. 2009 Feb;22(1):55-63. doi: 10.1111/j.1365-277X.2008.00920.x.

PMID:
19192027
18.

Pharmacologic therapy for obesity.

Udall JN Jr, Licciardi DM, Svec F.

J La State Med Soc. 2005 Jan;157 Spec No 1:S56-64. Review.

PMID:
15751911
19.

Safety profile of orlistat: results of a prescription-event monitoring study.

Acharya NV, Wilton LV, Shakir SA.

Int J Obes (Lond). 2006 Nov;30(11):1645-52. Epub 2006 Mar 21.

PMID:
16552401
20.

Effectiveness of a lifestyle modification programme in weight maintenance in obese subjects after cessation of treatment with Orlistat.

Woo J, Sea MM, Tong P, Ko GT, Lee Z, Chan J, Chow FC.

J Eval Clin Pract. 2007 Dec;13(6):853-9.

PMID:
18070255

Supplemental Content

Support Center